Dihydropyridines: evaluation of their current and future pharmacological applications N Edraki, AR Mehdipour, M Khoshneviszadeh, R Miri Drug Discovery Today 14 (21-22), 1058-1066, 2009 | 315 | 2009 |
Synthesis and biological evaluation of some new 1, 4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents M Khoshneviszadeh, N Edraki, K Javidnia, A Alborzi, B Pourabbas, ... Bioorganic & Medicinal Chemistry 17 (4), 1579-1586, 2009 | 121 | 2009 |
Novel tacrine-coumarin hybrids linked to 1, 2, 3-triazole as anti-Alzheimer’s compounds: In vitro and in vivo biological evaluation and docking study Z Najafi, M Mahdavi, M Saeedi, E Karimpour-Razkenari, N Edraki, ... Bioorganic chemistry 83, 303-316, 2019 | 120 | 2019 |
Design, synthesis and anti-Alzheimer’s activity of novel 1, 2, 3-triazole-chromenone carboxamide derivatives A Rastegari, H Nadri, M Mahdavi, A Moradi, SS Mirfazli, N Edraki, ... Bioorganic chemistry 83, 391-401, 2019 | 99 | 2019 |
Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties … A Iraji, O Firuzi, M Khoshneviszadeh, M Tavakkoli, M Mahdavi, H Nadri, ... European journal of medicinal chemistry 141, 690-702, 2017 | 86 | 2017 |
Design, synthesis and biological evaluation of novel anti-cytokine 1, 2, 4-triazine derivatives M Khoshneviszadeh, MH Ghahremani, A Foroumadi, R Miri, O Firuzi, ... Bioorganic & medicinal chemistry 21 (21), 6708-6717, 2013 | 77 | 2013 |
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands A Iraji, M Khoshneviszadeh, O Firuzi, M Khoshneviszadeh, N Edraki Bioorganic Chemistry 97, 103649, 2020 | 76 | 2020 |
Click chemistry-assisted synthesis of novel aminonaphthoquinone-1, 2, 3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations M Gholampour, S Ranjbar, N Edraki, M Mohabbati, O Firuzi, ... Bioorganic Chemistry 88, 102967, 2019 | 76 | 2019 |
Chemical composition of Ferula persica Wild. essential oil from Iran K Javidnia, R Miri, M Kamalinejad, N Edraki Flavour and fragrance journal 20 (6), 605-606, 2005 | 76 | 2005 |
Synthesis of novel chromenones linked to 1, 2, 3-triazole ring system: Investigation of biological activities against Alzheimer’s disease M Saeedi, M Safavi, E Karimpour-Razkenari, M Mahdavi, N Edraki, ... Bioorganic chemistry 70, 86-93, 2017 | 75 | 2017 |
Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids Z Najafi, M Saeedi, M Mahdavi, R Sabourian, M Khanavi, MB Tehrani, ... Bioorganic chemistry 67, 84-94, 2016 | 72 | 2016 |
Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1, 2, 4-triazine scaffold containing pendant phenoxy methyl-1, 2, 3-triazole: Design, synthesis and … M Yazdani, N Edraki, R Badri, M Khoshneviszadeh, A Iraji, O Firuzi Bioorganic chemistry 84, 363-371, 2019 | 71 | 2019 |
Phenylimino-2H-chromen-3-carboxamide derivatives as novel small molecule inhibitors of β-secretase (BACE1) N Edraki, O Firuzi, A Foroumadi, R Miri, A Madadkar-Sobhani, ... Bioorganic & medicinal chemistry 21 (8), 2396-2412, 2013 | 67 | 2013 |
Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease A Iraji, O Firuzi, M Khoshneviszadeh, H Nadri, N Edraki, R Miri Bioorganic chemistry 77, 223-235, 2018 | 64 | 2018 |
Phenoxyethyl piperidine/morpholine derivatives as PAS and CAS inhibitors of cholinesterases: insights for future drug design Y Pourshojaei, A Abiri, K Eskandari, Z Haghighijoo, N Edraki, A Asadipour Scientific reports 9 (1), 19855, 2019 | 63 | 2019 |
Constituents of the Volatile Oil of Ferulago angulata (Schlecht.) Boiss. from Iran K Javidnia, R Miri, N Edraki, M Khoshneviszadeh, A Javidnia Journal of essential oil research 18 (5), 548-550, 2006 | 62 | 2006 |
Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer’s disease Z Haghighijoo, O Firuzi, B Hemmateenejad, S Emami, N Edraki, R Miri Bioorganic Chemistry 74, 126-133, 2017 | 54 | 2017 |
Discovery of imidazopyridines containing isoindoline-1, 3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis S Azimi, A Zonouzi, O Firuzi, A Iraji, M Saeedi, M Mahdavi, N Edraki European Journal of Medicinal Chemistry 138, 729-737, 2017 | 50 | 2017 |
Cytotoxic activity evaluation and QSAR study of chromene-based chalcones L Firoozpour, N Edraki, M Nakhjiri, S Emami, M Safavi, SK Ardestani, ... Archives of pharmacal research 35, 2117-2125, 2012 | 50 | 2012 |
Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity F Vafadarnejad, M Mahdavi, E Karimpour-Razkenari, N Edraki, ... Bioorganic Chemistry 77, 311-319, 2018 | 47 | 2018 |